Laquinimod [CAS 248281-84-7]
Partner: MedChemexpress LLC
| CAS No: | 248281-84-7 |
| Applications: | COVID-19-immunoregulation |
| MW: | 356.80 |
| Formula: | C19H17ClN2O3 |
| SMILES: | O=C(C1=C(O)C2=C(N(C)C1=O)C=CC=C2Cl)N(CC)C3=CC=CC=C3 |
| Purity: | 99.96 |
| Description: | Laquinimod (ABR-215062), an orally available carboxamide derivative, is a potent immunomodulator which prevents neurodegeneration and inflammation in the central nervous system. Laquinimod reduces astrocytic NF-?B activation to protect from Cuprizone-induced demyelination. Laquinimod has�the�potential�for relapsing remitting (RR) and chronic progressive (CP) forms of multiple sclerosis (MS; RRMS or CPMS) as well as neurodegenerative diseases�research[1][2][3][4]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
